Which rate describes the MRSA situation appropriately?;Welche rate beschreibt die MRSA-situation am besten?

Deutsche Medizinische Wochenschrift

Volumn 132, Issue 27, 2007, Pages 1480-1482

  Gastmeier, P ^a   Chaberny, Iris F ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Epidemiology; MRSA; Nosocomial; Prevention

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIUM ISOLATE; HUMAN; INCIDENCE; INFECTION CONTROL; INTENSIVE CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NOTE; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS; ARTICLE; CROSS INFECTION; DISEASE TRANSMISSION; DRUG EFFECT; ECONOMICS; HEALTH CARE COST; LENGTH OF STAY; MORTALITY; PATHOGENICITY; PENICILLIN RESISTANCE; STAPHYLOCOCCUS INFECTION; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTIINFECTIVE AGENT; METICILLIN;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; METHICILLIN; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 34447131466     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-982056     Document Type: Note

References (10)

1. Anonymous. Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen: Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsbl 1999; 42: 954-958
2. Chaberny IF, Sohr D, Ruden H, Gastmeier P. Development of a Surveillance System for Methicillin-Resistant Staphylococcus aureus in German Hospitals. Infect Control Hosp Epidemiol 2007; 28: 446-452
3. Chaberny IF, Sohr D, Rüden H, Gastmeier P. Surveillance of MRSA over 3 years shows a significant reduction of the nosocomial MRSA incidence density - analysis of 26 German MRSA-KISS hospitals. J Hosp Infect 2006; 64: S82
4. Chaberny IF, Ziesing S, Mattner F et al. The burden of MRSA in four German university hospitals. Int J Hyg Environ Health 2005; 208: 447-453
5. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26: 166-174
6. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36: 53-59
7. Engemann JJ, Carmeli Y, Cosgrove SE et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003; 36: 592-598
8. Merrer J, Santoli F, Appere de Vecchi V, Tran B, De Jonghe B, Outin H. "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000; 21: 718-723
9. Meyer E, Schwab F, Pollitt A, Trautmann M. Resistance rates in ICUs: interpretation and pitfalls. J Hosp Infect 2007; 65: 84-85
10. Wernitz MH, Keck S, Swidsinski S, Schulz S, Veit SK. Cost analysis of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers in the context of diagnosis related groups (DRG) payment. Clin Microbiol Infect 2005; 11: 466-471